3-(2-Methyl-1H-indol-5-yl)-3-phenyl-acrylic acid ethyl ester → N-Methyl-3-(2-methyl-1H-indol-5-yl)-3-phenyl-acrylamide
반응식
C(O[C:4](=[O:23])[CH:5]=[C:6]([C:13]1[CH:14]=[C:15]2[C:19](=[CH:20][CH:21]=1)[NH:18][C:17]([CH3:22])=[CH:16]2)[C:7]1[CH:12]=[CH:11][CH:10]=[CH:9][CH:8]=1)C.[NH:24]1C2C(=CC=CC=2C(C2C=CC=CC=2)=CC(NC)=O)C=[CH:25]1>>[CH3:25][NH:24][C:4](=[O:23])[CH:5]=[C:6]([C:13]1[CH:14]=[C:15]2[C:19](=[CH:20][CH:21]=1)[NH:18][C:17]([CH3:22])=[CH:16]2)[C:7]1[CH:12]=[CH:11][CH:10]=[CH:9][CH:8]=1참가 물질
3
실험 절차
N-Methyl-3-(2-methyl-1H-indol-5-yl)-3-phenyl-acrylamide LXVIII (990 mg, 83%) was prepared from 3-(2-methyl-1H-indol-5-yl)-3-phenyl-acrylic acid ethyl ester using the procedure described for 3-(1H-indol-7-yl)-N-methyl-3-phenyl-acrylamide XVIII (see Example 4).
출처 및 근거
- ORD 기록
- ord-c43fc21932fe4a48b40dce3aa31521dd
- 출처 데이터셋
- uspto-grants-2008_11
- 특허 번호
- US07446118B2
반응 노트
불러오는 중…